Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
Bulls: Bet on a Rebound for This Telehealth Stock
12:45pm, Friday, 22'nd Nov 2024
Subscribers to Schaeffer's Weekend Trader options recommendation service received this HIMS commentary on Sunday night, along with a detailed options trade recommendation -- including complete entry a
Hims & Hers New Growth Category Is a Huge Surprise
11:59am, Friday, 22'nd Nov 2024
Is the food business the right business for Hims & Hers to be in?
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
10:01am, Friday, 22'nd Nov 2024
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
What's Happening With HIMS Stock?
08:55am, Friday, 22'nd Nov 2024
The stock price of Hims & Hers Health (NYSE: HIMS), a telehealth platform, has risen a solid 14% in a week. Much of this move came after the U.S. FDA asked for more time to confirm the shortage of Eli
The FDA Can't Decide Whether Zepbound Is in Shortage. It's Good News for Hims & Hers Stock.
04:56pm, Thursday, 21'st Nov 2024
Hims & Hers markets a compounded version of a similar medicine sold by Novo Nordisk.
Hims & Hers Expands Nutrition Support to Fuel Customers' Weight Loss Journeys
12:00pm, Thursday, 21'st Nov 2024
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that Hims & Hers customers will now be able to suppl
Hims & Hers Health: Far From Dead, Even With Amazon's Threat Ahead
01:15pm, Wednesday, 20'th Nov 2024
Hims & Hers Health can potentially face significant competition from Amazon's aggressive pricing and broad telehealth offerings, but its personalized care and strong financials offer resilience. Not e
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
06:00am, Monday, 18'th Nov 2024
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS), the leading health and wellness platform, today announced Deb Autor, former deputy commissioner at the FDA, w
Hims & Hers Stock Is Down 30% This Week: Here's What Happened
10:30am, Saturday, 16'th Nov 2024
Hims & Hers has given back recent gains, but don't overlook the company's massive growth.
Should You Buy Hims & Hers Stock on the Dip?
07:15am, Saturday, 16'th Nov 2024
Should You Buy Hims & Hers Stock on the Dip?
Hims & Hers: Revolutionizing Telehealth And Captivating Investors - Here's Why You Should Buy
04:40am, Saturday, 16'th Nov 2024
Hims & Hers stands out from Teladoc by focusing on direct-to-consumer telehealth services, contrasting Teladoc's business-to-business model. This telehealth company provides personalized treatments to
Hims & Hers Health: The Amazon Curse Is Being Overstated
12:37pm, Friday, 15'th Nov 2024
Hims & Hers Health, Inc.'s stock dropped over 25% over the last 2 days due to Amazon's entry into the hair loss and ED markets, but I believe investor pessimism is overblown. Despite Amazon's competit
Hims & Hers stock tanks as Amazon debuts fixed pricing for hair-loss and erectile-dysfunction drugs
08:10am, Friday, 15'th Nov 2024
Hims & Hers Health, a telehealth service for clients to access healthcare and prescriptions from home, is seeing its stock take a steep dive on Thursday, just after Amazon announced updates to a strik
Hims & Hers' stock tumbles on Amazon's latest disruptive foray into healthcare
02:40pm, Thursday, 14'th Nov 2024
Amazon is now offering upfront pricing for virtual care for ailments such as men's hair loss and ED.
Amazon's push into telehealth knocks shares of Hims & Hers
11:18am, Thursday, 14'th Nov 2024
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits.
